Novavax says Phase 3 trial of omicron-targeting COVID vaccine supports its use as a booster
admin Novavax Inc. NVAX, -1.88% said Tuesday a late-stage trial of its vaccine targeting the COVID…
Read MoreOmicrontargeting
Pfizer and BioNTech report positive data in trial of omicron-targeting bivalent booster in individuals aged 18 and older
Pfizer Inc. PFE, +0.26% and German partner BioNTech SE BNTX, +5.53% said Thursday early data…
Read More1 in 5 of Americans don’t know about new omicron-targeting COVID boosters, survey finds
About half of the American public has heard little or nothing about the new COVID-19…
Read More1 in 5 of Americans don’t know about new omicron-targeting COVID boosters, survey finds
About half of the American public has heard little or nothing about the new COVID-19…
Read MoreOmicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake
The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week…
Read MoreOmicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read More